US EditionPublished • loading... • Updated
Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
- Eli Lilly and Company announced two new appointments to its Executive Committee to enhance its growth strategy and expand leadership roles.
- Carole Ho, M.D., has been appointed as executive vice president and president of Lilly Neuroscience, joining the Executive Committee.
- Adrienne Brown has been promoted to executive vice president and president of Lilly Immunology and will also join the Executive Committee.
- Daniel Skovronsky, M.D., Ph.D., will expand his role overseeing significant areas in research and development.
Insights by Ground AI
35 Articles
35 Articles
The Berkshire Eagle+34 Reposted by 34 other sources
Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles designed to accelerate one of the industry's most ambitious pipelines,…
Coverage Details
Total News Sources35
Leaning Left2Leaning Right5Center11Last UpdatedBias Distribution61% Center
Bias Distribution
- 61% of the sources are Center
61% Center
11%
C 61%
R 28%
Factuality
To view factuality data please Upgrade to Premium
